PharmaCord Announces Appointment of Robert Truckenmiller as CEO
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
Vaccine
PharmaCord Announces Appointment of Robert Truckenmiller as CEO
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters...
MEDIROM MOTHER Labs Provides MOTHER Bracelet®︎ Device and Remote Health Monitoring System, REMONY, to TOPPAN Inc.
TOKYO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare technologies Inc. (NASDAQ: MRM) (“MEDIROM”), a health technology and holistic healthcare...
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality
Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industriesNEW YORK, Jan. 21,...
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
COPENHAGEN, Denmark, January 20, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on...
Moderna Announces Updates on Pandemic Influenza Program
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S....
Healthcare Supply Chain Management Market to Hit USD 5.06 Billion by 2030 with 5.3 % CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Jan. 17, 2025 /PRNewswire/ -- The global healthcare supply chain management market, valued at US$ 3.51 billion in 2023,...
Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
Strategic hire underscores Emmes Group's growth and commitment to biopharma market ROCKVILLE, Md., Jan. 16, 2025 /PRNewswire/ -- Emmes Group®,...
Rapid Dose Completes Issuance of Shares as Payment of Directors’ Fees
Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to...
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) --...
Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema
MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...
Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by focus on nanotechnology, with a report on how AI is reshaping the landscape – Technavio
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global transmission electron microscope market...
National Inventors Hall of Fame Announces Vaccine and Surfboard Innovators Among 2025 Class
Honorees' Contributions to Society Are Centerpiece of May Event NORTH CANTON, Ohio, Jan. 15, 2025 /PRNewswire/ -- Seventeen innovation pioneers...
BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025
BioVaxys Technology Corp. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation...
BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025
BioVaxys Technology Corp. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation...
mctlaw Files Federal Takings Claim on Behalf of Small Business Landlord for Losses During CDC’s Eviction Moratorium
Washington, D.C.--(Newsfile Corp. - January 13, 2025) - mctlaw has filed a lawsuit in the United States Court of Federal...
TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers
SAN FRANCISCO, CALIFORNIA / ACCESSWIRE / January 13, 2025 / TheraVac Biologics (TheraVac), a company developing innovative immunotherapies for neurological...
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited)Updates...
NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing...